My Clinic is in the United States
My Clinic is in Canada
Two leading reproductive health companies joining forces to drive innovation and improve patient outcomes
TRUMBULL, Conn., February 16, 2021 – CooperSurgical, a leader in women’s health care solutions, announced a multi-year strategic collaboration, commencing this month, with Virtus Health, a leading global assisted reproductive services provider, to drive innovation, digitalization and advancement in fertility treatment.
Infertility affects approximately 15% of couples worldwide, an estimated 48.5 million couples.[i]
Central to the collaboration will be the advancement of Precision Fertility – Virtus’ strategy to develop an innovative digital platform that harnesses the power of Virtus’ significant and unique data set and enhances clinical and scientific decisions with insights gained via artificial intelligence and machine learning.
By combining CooperSurgical’s scientific leadership, illustrated by its position at the vanguard of pre-implantation genetic testing with its revolutionary PGTaiSM technology platform, and the applied medical expertise of Virtus, the collaboration will spearhead projects to benefit patients’ fertility journeys, including those who need egg, sperm or embryo donations, with a focus on digitalization, cryogenics and reproductive genetics.
Together Virtus and CooperSurgical will work to develop enhanced processes and systems that guide laboratory management optimization and improve patient treatment outcomes.
“This collaboration exemplifies CooperSurgical’s commitment to advancing the world of fertility and moves us forward in our aim to positively impact every IVF patient — every cycle, every embryo and every outcome,” said Holly Sheffield, President, CooperSurgical. “By harnessing our complementary strengths within fertility technology and care, we aim to improve standards of treatments to optimize the patient journey.”
“Virtus is a high-performing organization committed to operational excellence as well as clinical and scientific innovation,” said Kate Munnings, Virtus Health Group CEO. “This partnership will advance our cutting-edge science and technology, allowing us to offer patients the most advanced IVF services.”
About Virtus Health Limited
Virtus Health Limited (ASX: VRT) brings together leading clinicians, scientists, researchers and support staff to provide the very best in fertility care and related specialized diagnostic and day hospital services. We have developed one of the most successful medical collaborations in the world. With 120 of the world’s leading fertility specialists supported by over 1200 professional staff, we are one of the world’s top five Assisted Reproductive Service providers with clinics in Australia, Ireland, UK, Denmark and Singapore.
About CooperSurgical
For more than 25 years, CooperSurgical has been a leader in manufacturing, marketing a wide range of trusted and innovative brands that have assisted clinicians in advancing the standard of health care for women and families worldwide. CooperSurgical is at the forefront of delivering innovative assisted reproductive technology and genomic solutions that enhance the work of ART professionals to the benefit of families.
CooperSurgical is a wholly-owned subsidiary of CooperCompanies (NYSE: COO). CooperSurgical, headquartered in Trumbull, Conn., produces and markets a wide array of products and services for use by women’s health care clinicians.
About CooperCompanies
CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
CooperSurgical
Caren Begun
Green Room Communications
201-396-8551
[email protected]
[i] Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13:37. Published 2015 Apr 26. https://rbej.biomedcentral.com/articles/10.1186/s12958-015-0032-1. Accessed February 02, 2021.
